![Mark Casey](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Mark Casey
Consigliere Generale presso
NOVAVAX, INC.
Patrimonio netto: 848 431 $ in data 30/06/2026
Profilo
Mark Joseph Casey is Secretary, Chief Legal Officer & Executive VP at Novavax, Inc. since 2023.
Former roles include Secretary & Chief Legal Officer at Bryn Pharma LLC in 2023; Chief Legal Officer & Executive Vice President at Keenova Therapeutics Plc from 2018 to 2022; Secretary, Senior Vice President & General Counsel at Idera Pharmaceuticals, Inc. from 2015 to 2018; Secretary, Chief Administrative Officer & SVP at Hologic, Inc. from 2012 to 2014; Chief Patent Counsel, VP & Deputy General Counsel at Cytyc Corp.
from 2002 to 2007; Attorney at Boston Scientific Corp.
from 1998 to 2002; Attorney at EMC Corp.
from 1996 to 1998; Attorney at Digital Equipment Corp.
from 1992 to 1996; Director at MKG Medical UK Ltd. from 2020 to 2025; Director at Third Wave Technologies, Inc. in 2008; Director at AdvaMedDx; Chief Legal Officer & Executive Vice President at Mallinckrodt Pharmaceuticals Ltd. Education includes undergraduate studies at Syracuse University and graduate studies at Suffolk University Law School.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
NOVAVAX, INC. 0,05% | 23/04/2026 | 90.067 ( 0,05% ) | 848 431 $ | 30/06/2026 |
Posizioni attive di Mark Casey
| Società | Posizione | Inizio |
|---|---|---|
| NOVAVAX, INC. | Consigliere Generale | 11/12/2023 |
Precedenti posizioni note di Mark Casey
| Società | Posizione | Fine |
|---|---|---|
MKG Medical UK Ltd.
 MKG Medical UK Ltd. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Direttore/Membro del Consiglio | 15/01/2025 |
Bryn Pharma LLC
 Bryn Pharma LLC Medical SpecialtiesHealth Technology Develops bi-dose intranasal devices for patients with anaphylaxis | Consigliere Generale | 01/11/2023 |
| MALLINCKRODT PLC | Consigliere Generale | 15/09/2022 |
Idera Pharmaceuticals, Inc.
 Idera Pharmaceuticals, Inc. BiotechnologyHealth Technology Develops drug candidates for oncology and rare disease indications | Consigliere Generale | 31/01/2018 |
| HOLOGIC, INC. | Direttore Amministrativo | 19/12/2014 |
Formazione di Mark Casey
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
89
Relazioni di 1° grado
15
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 15 |
|---|---|
Digital Equipment Corp.
 Digital Equipment Corp. Computer Processing HardwareElectronic Technology Makes personal computers and servers | Electronic Technology |
EMC Corp.
 EMC Corp. Computer PeripheralsElectronic Technology Manufactures and sells computer storage devices and provides IT services | Electronic Technology |
Hologic, Inc.
 Hologic, Inc. Medical SpecialtiesHealth Technology Develops, manufactures and supplies diagnostics devices, medical imaging systems & surgical products for women's | Health Technology |
Boston Scientific Corp.
 Boston Scientific Corp. Medical SpecialtiesHealth Technology Develops, manufactures and markets cardiology, endoscopy, peripheral intervention, urology & neuromodulation equipment | Health Technology |
Idera Pharmaceuticals, Inc.
Idera Pharmaceuticals, Inc. BiotechnologyHealth Technology Develops drug candidates for oncology and rare disease indications | Health Technology |
Novavax, Inc.
 Novavax, Inc. BiotechnologyHealth Technology Engages in development of novel recombinant vaccines | Health Technology |
Cytyc Corp.
 Cytyc Corp. Medical SpecialtiesHealth Technology Manufactures and markets medical diagnostic applications | Health Technology |
Third Wave Technologies, Inc.
 Third Wave Technologies, Inc. BiotechnologyHealth Technology Develops DNA and RNA detection technology | Health Technology |
Keenova Therapeutics Plc
 Keenova Therapeutics Plc BiotechnologyHealth Technology Develops therapeutics for rheumatology, ophthalmology, nephrology, neurology, pulmonology, orthopedics, urology and neonatal respiratory problems | Health Technology |
Syracuse University
 Syracuse University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
AdvaMedDx
 AdvaMedDx Miscellaneous Commercial ServicesCommercial Services Operates as a trade association representing diagnostics manufacturers | Commercial Services |
Suffolk University Law School
 Suffolk University Law School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
MKG Medical UK Ltd.
MKG Medical UK Ltd. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Mallinckrodt Pharmaceuticals Ltd.
 Mallinckrodt Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Bryn Pharma LLC
Bryn Pharma LLC Medical SpecialtiesHealth Technology Develops bi-dose intranasal devices for patients with anaphylaxis | Health Technology |
